Authors:
LINSSENSCHUURMANS CD
VANKAN EJM
FEITH GW
UGES DRA
Citation: Cd. Linssenschuurmans et al., NEUROTOXICITY CAUSED BY VALACYCLOVIR IN A PATIENT ON HEMODIALYSIS, Therapeutic drug monitoring, 20(4), 1998, pp. 385-386
Authors:
WILLEMSEN MC
BRUG J
UGES DRA
VOSDEWAEL ML
Citation: Mc. Willemsen et al., VALIDITY AND RELIABILITY OF SELF-REPORTED EXPOSURE TO ENVIRONMENTAL TOBACCO-SMOKE IN WORK OFFICES, Journal of occupational and environmental medicine, 39(11), 1997, pp. 1111-1114
Citation: Ts. Vanderwerf et al., PHARMACOKINETICS OF PIPERACILLIN AND TAZOBACTAM IN CRITICALLY ILL PATIENTS WITH RENAL-FAILURE, TREATED WITH CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH), Intensive care medicine, 23(8), 1997, pp. 873-877
Authors:
DEJONG RS
SLIJFER EAM
UGES DRA
MULDER NH
DEVRIES EGE
Citation: Rs. Dejong et al., CONVERSION OF THE PRODRUG ETOPOSIDE PHOSPHATE TO ETOPOSIDE IN GASTRIC-JUICE AND BILE, British Journal of Cancer, 76(11), 1997, pp. 1480-1483
Authors:
HETTINGA JVE
LEMSTRA W
MEIJER C
DAM WA
UGES DRA
KONINGS AWT
DEVRIES EGE
KAMPINGA HH
Citation: Jve. Hettinga et al., MECHANISM OF HYPERTHERMIC POTENTIATION OF CISPLATIN ACTION IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT TUMOR-CELLS, British Journal of Cancer, 75(12), 1997, pp. 1735-1743
Authors:
DEJONG RS
MULDER NH
UGES DRA
KAUL S
WINOGRAD B
SLEIJFER DT
GROEN HJM
WILLEMSE PHB
VANDERGRAAF WTA
DEVRIES EGE
Citation: Rs. Dejong et al., RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE, British Journal of Cancer, 75(11), 1997, pp. 1660-1666
Citation: Rj. Vanginkel et al., HYPERTHERMIC ISOLATED LIMB PERFUSION WITH CISPLATIN IN 4 PATIENTS WITH SARCOMAS OF SOFT-TISSUE AND BONE, European journal of surgical oncology, 22(5), 1996, pp. 528-531
Authors:
VANWAARDENBURG RCAM
PRINS J
MEIJER C
UGES DRA
DEVRIES EGE
MULDER NH
Citation: Rcam. Vanwaardenburg et al., EFFECTS OF C-MYC ONCOGENE MODULATION ON DRUG-RESISTANCE IN HUMAN SMALL-CELL LUNG-CARCINOMA CELL-LINES, Anticancer research, 16(4A), 1996, pp. 1963-1970
Authors:
WITHOFF S
DEVRIES EGE
KEITH WN
NIENHUIS EF
VANDERGRAAF WTA
UGES DRA
MULDER NH
Citation: S. Withoff et al., DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-BETA IN P-GP AND MRP-NEGATIVE VM26, MAMSA AND MITOXANTRONE-RESISTANT SUBLINES OF THE HUMAN SCLC CELL-LINE GLC(4), British Journal of Cancer, 74(12), 1996, pp. 1869-1876
Authors:
DAENEN S
ERJAVEC Z
UGES DRA
DEVRIESHOSPERS HG
DEJONGE P
HALIE MR
Citation: S. Daenen et al., CONTINUOUS-INFUSION OF CEFTAZIDIME IN FEBRILE NEUTROPENIC PATIENTS WITH ACUTE MYELOID-LEUKEMIA, European journal of clinical microbiology & infectious diseases, 14(3), 1995, pp. 188-192
Authors:
DEGRAAF SSN
BLOEMHOF H
VENDRIG DEMM
UGES DRA
Citation: Ssn. Degraaf et al., VINCRISTINE DISPOSITION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Medical and pediatric oncology, 24(4), 1995, pp. 235-240
Citation: Rj. Vanginkel et al., HYPERTHERMIC ISOLATED REGIONAL PERFUSION WITH CISPLATIN IN THE LOCAL TREATMENT OF SPONTANEOUS CANINE OSTEOSARCOMA - ASSESSMENT OF SHORT-TERM EFFECTS, Journal of surgical oncology, 59(3), 1995, pp. 169-176
Authors:
GROEN HJM
VANDERLEEST AHD
DEVRIES EGE
UGES DRA
SZABO BG
MULDER NH
Citation: Hjm. Groen et al., CONTINUOUS CARBOPLATIN INFUSION DURING 6 WEEKS RADIOTHERAPY IN LOCALLY INOPERABLE NON-SMALL-CELL LUNG-CANCER - A PHASE-I AND PHARMACOKINETIC STUDY, British Journal of Cancer, 72(4), 1995, pp. 992-997
Authors:
GIETEMA JA
VELDHUIS GJ
GUCHELAAR HJ
WILLEMSE PHB
UGES DRA
CATS A
BOONSTRA H
VANDERGRAAF WTA
SLEIJFER DT
DEVRIES EGE
MULDER NH
Citation: Ja. Gietema et al., PHASE-II AND PHARMACOKINETIC STUDY OF LOBAPLATIN IN PATIENTS WITH RELAPSED OVARIAN-CANCER, British Journal of Cancer, 71(6), 1995, pp. 1302-1307
Authors:
SARK MWJ
TIMMERBOSSCHA H
MEIJER C
UGES DRA
SLUITER WJ
PETERS WHM
MULDER NH
DEVRIES EGE
Citation: Mwj. Sark et al., CELLULAR BASIS FOR DIFFERENTIAL SENSITIVITY TO CISPLATIN IN HUMAN GERM-CELL TUMOR AND COLON-CARCINOMA CELL-LINES, British Journal of Cancer, 71(4), 1995, pp. 684-690
Authors:
GUCHELAAR HJ
DEVRIES EGE
MEIJER C
ESSELINK MT
VELLENGA E
UGES DRA
MULDER NH
Citation: Hj. Guchelaar et al., EFFECT OF ULTRAFILTERABLE PLATINUM CONCENTRATION ON CISPLATIN AND CARBOPLATIN CYTOTOXICITY IN HUMAN TUMOR AND BONE-MARROW CELLS IN-VITRO, Pharmaceutical research, 11(9), 1994, pp. 1265-1269
Authors:
CROM WR
DEGRAAF SSN
SYNOLD T
UGES DRA
BLOEMHOF H
RIVERA G
CHRISTENSEN ML
MAHMOUD H
EVANS WE
Citation: Wr. Crom et al., PHARMACOKINETICS OF VINCRISTINE IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA, The Journal of pediatrics, 125(4), 1994, pp. 642-649
Authors:
SINNIGE HAM
BUTER J
DEVRIES EGE
UGES DRA
ROENHORST HW
VERSCHUEREN RCJ
SLEIJFER DT
WILLEMSE PHB
MULDER NH
Citation: Ham. Sinnige et al., PHASE I-II STUDY OF THE ADDITION OF ALPHA-2A INTERFERON TO 5-FLUOROURACIL LEUCOVORIN - PHARMACOKINETIC INTERACTION OF ALPHA-2A INTERFERON AND LEUCOVORIN, European journal of cancer, 29A(12), 1993, pp. 1715-1720
Authors:
GUCHELAAR HL
TIMMERBOSSCHA H
DAMMEIRING A
UGES DRA
OOSTERHUIS JW
DEVRIES EGE
MULDER NH
Citation: Hl. Guchelaar et al., ENHANCEMENT OF CISPLATIN AND ETOPOSIDE CYTOTOXICITY AFTER ALL-TRANS-RETINOIC-ACID-INDUCED CELLULAR-DIFFERENTIATION OF A MURINE EMBRYONAL CARCINOMA CELL-LINE, International journal of cancer, 55(3), 1993, pp. 442-447